Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man
2004 ◽
Vol 13
(7)
◽
pp. 841-855
◽
2006 ◽
Vol 13
(14)
◽
pp. 1635-1653
◽
2013 ◽
Vol 31
(3)
◽
pp. 327-330
◽
1998 ◽
Vol 31
◽
pp. 69